1
|
Alhuthil RT, Hijazi RM, Alyabes OA, Alsuhaibani MA, Gashgarey DA, Binsalamah IM, Aldahmash MA, Alghamdi SM, Albanyan EA, Aljumaah SA, Al-Hajjar SH. Epidemiology, clinical profiles, and antimicrobial susceptibility of Elizabethkingia meningoseptica infections: Insights from a tertiary care hospital in Saudi Arabia. Saudi Med J 2024; 45:840-847. [PMID: 39074884 PMCID: PMC11288499 DOI: 10.15537/smj.2024.45.8.20240279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Accepted: 07/04/2024] [Indexed: 07/31/2024] Open
Abstract
OBJECTIVES To investigate the incidence rate, clinical characteristics across different age groups, antimicrobial susceptibility, and outcomes of Elizabethkingia meningoseptica (E. meningoseptica) infections. METHODS A retrospective analysis was carried out to include 66 cases with confirmed E. meningoseptica cultures from sterile samples between January 2014 and June 2022 at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia. RESULTS A total of 66 cases were identified, with an incidence rate of 0.3 per 1000 admissions. Most cases were hospital-acquired (80.3%), primarily in critical care areas. All patients had underlying diseases, with respiratory (40.9%) and cardiovascular (39.4%) diseases being the most common. Minocycline showed the highest susceptibility (96.0%), followed by trimethoprim/sulfamethoxazole (77.0%), whereas tobramycin and colistin were fully resistant. The in-hospital mortality rate was 34.8%, whereas the 28-day mortality rate was 22.7%. Clinical characteristics across age groups showed a higher prevalence of cardiovascular disease in pediatrics than in adults, whereas exposure to mechanical ventilation, immunosuppressive therapy, previous infection, anemia, and in-hospital mortality were reported more frequently in adults (p<0.05). CONCLUSION Our study provides valuable insights into E. meningoseptica infection in Saudi Arabia, emphasizing the importance of robust infection control measures. Incidence and mortality rates align with global trends. Variations in clinical characteristics across age groups highlight the importance of tailored treatments based on patient demographics and underlying comorbidities.
Collapse
Affiliation(s)
- Raghad T. Alhuthil
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Raghad M. Hijazi
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Ohoud A. Alyabes
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Mohammed A. Alsuhaibani
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Deema A. Gashgarey
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Ibrahim M. Binsalamah
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Mohammed A. Aldahmash
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Salem M. Alghamdi
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Esam A. Albanyan
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Suliman A. Aljumaah
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| | - Sami H. Al-Hajjar
- From the Department of Pediatrics (Alhuthil, Alyabes, Alsuhaibani, Gashgarey, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), King Faisal Specialist Hospital & Research Centre, and from the College of Medicine (Hijazi, Alyabes, Alsuhaibani, Binsalamah, Aldahmash, Alghamdi, Albanyan, Aljumaah, Al-Hajjar), Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
| |
Collapse
|
3
|
Alshammari MK, Alsanad AH, Alnusayri RJ, Alanazi AS, Shamakhi FQ, Alshahrani KM, Alshahrani AM, Yahya G, Alshahrani AA, Alshahrani TS, Sultan HS, Alshahrani FM, Alreshidi FA, Alnigaidan RA, Almazyad AA. Risk and diagnostic factors and therapy outcome of neonatal early onset sepsis in ICU patients of Saudi Arabia: a systematic review and meta analysis. Front Pediatr 2023; 11:1206389. [PMID: 37681202 PMCID: PMC10482413 DOI: 10.3389/fped.2023.1206389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Accepted: 08/03/2023] [Indexed: 09/09/2023] Open
Abstract
Background Neonatal early onset sepsis (NEOS) is a serious and potentially life-threatening condition affecting newborns within the first few days of life. While the diagnosis of NEOS was based on clinical signs and symptoms in the past, recent years have seen growing interest in identifying specific diagnostic factors and optimizing therapy outcomes. This study aims to investigate the diagnostic and risk factors and therapy outcomes of neonatal EOS in ICU patients in Saudi Arabia, with the goal of improving the management of neonatal EOS in the country. Methods This method outlines the protocol development, search strategy, study selection, and data collection process for a systematic review on neonatal early onset sepsis in Saudi Arabian ICU patients, following the PRISMA 2020 guidelines. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a well-established guideline that provides a framework for conducting systematic reviews and meta-analyses in a transparent and standardized manner. It aims to improve the quality and reporting of such research by ensuring clear and comprehensive reporting of study methods, results, and interpretations. The search strategy included electronic databases (PubMed, Embase, Google Scholar, Science Direct, and the Cochrane Library) and manual search of relevant studies, and data were extracted using a standardized form. Results The systematic review included 21 studies on neonatal sepsis in Saudi Arabia, with varying study designs, sample sizes, and prevalence rates of sepsis. Group B streptococcus and E. coli were the most commonly isolated pathogens. Various diagnostic factors and risk factors were reported, including hematological parameters, biomarkers, and blood cultures. The quality of the included studies was assessed using the Newcastle-Ottawa Scale and Joanna Briggs Institute critical checklist. Conclusions The review identified a number of risk and diagnostic factors and therapy outcomes for neonatal sepsis. However, most of the studies were having small scale cohort groups. Further research with controlled study designs is needed to develop effective prevention and management strategies for neonatal sepsis in Saudi Arabia.
Collapse
Affiliation(s)
| | - Ahlam H. Alsanad
- Department of Neonatal Intensive Care Unit, Maternity and Children Hospital, Dammam, Saudi Arabia
| | - Rawan J. Alnusayri
- Department of Pharmacy, Maternity and Children Hospital, Ministry of Health, Jouf, Saudi Arabia
| | | | | | | | | | - Ghaliah Yahya
- Department of Medicine, Ministry of Health, Abha, Saudi Arabia
| | | | | | - Hamad S. Sultan
- College of Medicine, King Khalid University, Al Fara, Saudi Arabia
| | | | | | - Renad A. Alnigaidan
- Department of Pharmacy, Al-Dawaa Medical Services Company Limited, Unaizah, Saudi Arabia
| | - Abdulaziz A. Almazyad
- Department of Pharmacy, Qassim University Medical City Hospital, Buraidah, Saudi Arabia
| |
Collapse
|
4
|
Li Y, Liu T, Shi C, Wang B, Li T, Huang Y, Xu Y, Tang L. Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China. Front Public Health 2022; 10:964046. [PMID: 36225778 PMCID: PMC9549487 DOI: 10.3389/fpubh.2022.964046] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 08/22/2022] [Indexed: 01/24/2023] Open
Abstract
Background Elizabethkingia meningoseptica is a bacterium causing potential nosocomial infections and is associated with a high mortality rate; however, the date of patients in the Hefei population who have been diagnosed with this infection is generally limited. Purpose The clinical and laboratory data of patients from a tertiary hospital in Hefei City who had E. meningoseptica infection were evaluated in this retrospective analysis. Patients and methods From May 2017 to November 2021, there were 24 patients infected with E. meningoseptica in the First Affiliated Hospital of Anhui Medical University. Data were gathered from the hospital's electronic medical records for all patients. Results The most prevalent symptom among the 24 patients was fever (83.3%), followed by edema (41.7%), cough (37.5%), altered consciousness (41.7%), and sputum (37.5%), and laboratory results presented with anemia (75%), hypoproteinemia (75%), elevated C-reactive protein (CRP) (66.7%), neutrophilia (54.2%), and leukocytosis (50.0%). Hepatic disease (1 vs. 7, P = 0.009) was the only significant risk factor for underlying diseases. The mean value of lymphocyte (LYMPH#) (1.4 vs. 0.83 × 109/L, P = 0.033) counts was higher in the survival group than death group, while both anemia (8 vs. 10, P = 0.024) and hypoproteinemia (8 vs. 10, P = 0.024) occurred more frequently in the death group compared with the survival one. Conclusion Fever was the most common symptom and the only significant factor of underlying diseases was hepatic disease (P = 0.009) that often occurred in death groups. In this investigation, the risk factors for death in patients were anemia, hypoproteinemia, and lymphocyte count. The susceptibility of some quinolones, piperacillin-tazobactam, and cotrimoxazole was relatively high, suggesting that they may be the preferred drugs for the treatment of E. meningoseptica infection. As E. meningoseptica can produce biofilm to pollute the hospital environment and cause infection in patients, the disinfection of the hospital environment should be strengthened and medical staff should pay attention to aseptic operations.
Collapse
|
5
|
Idrees M, Noorani MY, Altaf KU, Alatawi EA, Aba Alkhayl FF, Allemailem KS, Almatroudi A, Ali Khan M, Hamayun M, Khan T, Ali SS, Khan A, Wei DQ. Core-Proteomics-Based Annotation of Antigenic Targets and Reverse-Vaccinology-Assisted Design of Ensemble Immunogen against the Emerging Nosocomial Infection-Causing Bacterium Elizabethkingia meningoseptica. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 19:194. [PMID: 35010455 PMCID: PMC8750920 DOI: 10.3390/ijerph19010194] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 12/06/2021] [Accepted: 12/14/2021] [Indexed: 12/16/2022]
Abstract
Elizabethkingia meningoseptica is a ubiquitous Gram-negative emerging pathogen that causes hospital-acquired infection in both immunocompromised and immunocompetent patients. It is a multi-drug-resistant bacterium; therefore, an effective subunit immunogenic candidate is of great interest to encounter the pathogenesis of this pathogen. A protein-wide annotation of immunogenic targets was performed to fast-track the vaccine development against this pathogen, and structural-vaccinology-assisted epitopes were predicted. Among the total proteins, only three, A0A1T3FLU2, A0A1T3INK9, and A0A1V3U124, were shortlisted, which are the essential vaccine targets and were subjected to immune epitope mapping. The linkers EAAK, AAY, and GPGPG were used to link CTL, HTL, and B-cell epitopes and an adjuvant was also added at the N-terminal to design a multi-epitope immunogenic construct (MEIC). The computationally predicted physiochemical properties of the ensemble immunogen reported a highly antigenic nature and produced multiple interactions with immune receptors. In addition, the molecular dynamics simulation confirmed stable binding and good dynamic properties. Furthermore, the computationally modeled immune response proposed that the immunogen triggered a strong immune response after several doses at different intervals. Neutralization of the antigen was observed on the 3rd day of injection. Conclusively, the immunogenic construct produces protection against Elizabethkingia meningoseptica; however, further immunological testing is needed to unveil its real efficacy.
Collapse
Affiliation(s)
- Muhammad Idrees
- Center for Biotechnology and Microbiology, University of Swat, Swat 19200, Khyber Pakhtunkhwa, Pakistan; (M.I.); (S.S.A.)
| | | | | | - Eid A. Alatawi
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia;
| | - Faris F. Aba Alkhayl
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; (F.F.A.A.); (K.S.A.)
- Department of Pharmaceutical Chemistry and Pharmacognosy, College of Dentistry and Pharmacy, Buraydah Colleges, Buraydah 51418, Saudi Arabia
| | - Khaled S. Allemailem
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; (F.F.A.A.); (K.S.A.)
| | - Ahmad Almatroudi
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; (F.F.A.A.); (K.S.A.)
| | - Murad Ali Khan
- Department of Chemistry, Kohat University of Sciences and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan;
| | - Muhammad Hamayun
- Department of Botany, Abdul Wali Khan University, Mardan 23200, Khyber Pakhtunkhwa, Pakistan;
| | - Taimoor Khan
- Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; (T.K.); (A.K.)
| | - Syed Shujait Ali
- Center for Biotechnology and Microbiology, University of Swat, Swat 19200, Khyber Pakhtunkhwa, Pakistan; (M.I.); (S.S.A.)
| | - Abbas Khan
- Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; (T.K.); (A.K.)
| | - Dong-Qing Wei
- Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China; (T.K.); (A.K.)
- Peng Cheng Laboratory, Shenzhen 518066, China
- State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, China
| |
Collapse
|